The effect of anti-migraine compounds on nitric oxide-induced dilation of dural meningeal vessels

European Journal of Pharmacology

Volumn 452, Issue 2, 2002, Pages 223-228

  Akerman, Simon ^a   Williamson, David J ^b   Kaube, Holger ^a   Goadsby, Peter J ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

Intravital microscopy; Meningeal artery, middle; Migraine; Nitric oxide (NO); Trigeminal

Indexed keywords

ANTIMIGRAINE AGENT; CALCITONIN GENE RELATED PEPTIDE; FLUNARIZINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; INDOMETACIN; NITRIC OXIDE; SUMATRIPTAN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; MALE; MENINX; MICROSCOPY; MIGRAINE; MONITORING; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; REPRODUCIBILITY; TRIGEMINAL NERVE; VASODILATATION;

ANALGESICS; ANIMALS; DURA MATER; MALE; MENINGEAL ARTERIES; MIGRAINE DISORDERS; NITRIC OXIDE; NITRIC OXIDE DONORS; RATS; RATS, SPRAGUE-DAWLEY; VASODILATION;

EID: 0037020466     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02307-5     Document Type: Article

References (33)

1. Abdel-Halim M.S., Sjoquist B., Anggard E. Inhibition of prostaglandin synthesis in the rat brain. Acta Pharmacol. Toxicol. 43:1978;266-272.
2. Akerman S., Williamson D., Hill R.G., Goadsby P.J. The effect of adrenergic compounds on neurogenic dural vasodilatation. Eur. J. Pharmacol. 424:2001;53-58.
3. Akerman S., Williamson D., Kaube H., Hill R.G., Goadsby P.J. The effect of histamine and histamine antagonists on rat dural meningeal vessels. Cephalalgia. 21:2001;352.
4. Akerman S., Williamson D., Kaube H., Hill R.G., Goadsby P.J. The effect of nitric oxide and nitric oxide synthase inhibitors on rat dural meningeal vessels. Cephalalgia. 21:2001;276-277.
5. Akerman S., Williamson D.J., Kaube H., Goadsby P.J. Nitric oxide synthase inhibitors can antagonise neurogenic and calitonin gene-related peptide induced dilation of dural meningeal vessels. Br. J. Pharmacol. 2002;. (in press).
6. Ayajiki K., Okamura T., Toda N. Flunarizine, an anti-migraine agent, impairs nitroxidergic nerve function in cerebral arteries. Eur. J. Pharmacol. 329:1997;49-53.
7. Castellano A.E., Micieli G., Bellantonio P., Buzzi M.G., Marcheselli S., Pompeo F., Rossi F., Nappi G. Indomethacin increases the effect of isosorbide dinitrate on cerebral hemodynamics in migraine patients: pathogenetic and therapeutic implications. Cephalalgia. 18:1998;622-630.
8. Coderre T.J., Gonzales R., Goldyne M.E., West J., Levine J.D. Noxious stimulus-induced increase in spinal prostaglandin-E2 is noradrenergic terminal-dependent. Neurosci. Lett. 115:1990;253-258.
9. 2+ channel blockers lidoflazine and flunarizine. Neurosci. Lett. 158:1993;97-100.
10. Goadsby P.J., Lipton R.B., Ferrari M.D. Migraine: current understanding and management. N. Engl. J. Med. 346:2002;257-270.
11. Headache Classification Committee of The International Headache Society Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 8:1988;1-96.
12. Hingtgen C.M., Waite K.J., Vasko M.R. Prostaglandins facilitate peptide release from rat sensory neurons by activating the adenosine 3′,5′-cyclic-monophosphate transduction cascade. J. Neurosci. 15:1995;5411-5419.
13. Iversen H.K., Olesen J. Nitroglycerin-induced headache is not dependent on histamine release: support for a direct nociceptive action of nitric oxide. Cephalalgia. 14:1994;437-442.
14. Iversen H.K., Olesen J. Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan - a human model for development of migraine drugs. Cephalalgia. 16:1996;412-418.
15. Iversen H.K., Olesen J., Tfelt-Hansen P. Intravenous nitroglycerin as an experimental headache model. Basic characteristics. Pain. 38:1989;17-24.
16. Krabbe A.E., Olesen J. Headache provocation by continuous intravenous infusion of histamine. Clinical results and receptor mechanisms. Pain. 8:1980;253-259.
17. 1-receptor. Support for the NO hypothesis of migraine. NeuroReport. 6:1995;1475-1479.
18. Leone M., Grazzi L., Mantia L.L., Bussone G. Flunarizine in migraine: a mini review. Headache. 31:1991;388-391.
19. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109-142.
20. Olesen J., Iversen H.K., Thomsen L.L. Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain. NeuroReport. 4:1993;1027-1030.
21. Olesen J., Thomsen L.L., Iversen H.K. Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol. Sci. 15:1994;149-153.
22. Read S.J., Manning P., McNeil C.J., Hunter A.J., Parsons A.A. Effects of sumatriptan on nitric oxide and superoxide balance during glyceryl trinitrate infusion in the rat. Implications for antimigraine mechanisms. Brain Res. 847:1999;1-8.
23. Sakai M., Minami T., Hara N., Nishihara I., Kitade H., Kamiyama Y., Okuda K., Takahashi H., Mori H., Ito S. Stimulation of nitric oxide release from rat spinal cord by prostaglandin E-2. Br. J. Pharmacol. 123:1998;890-894.
24. Tassorelli C., Costa A., Blandini F., Joseph S.A., Nappi G. Effect of nitric oxide donors on the central nervous system - nitroglycerin studies in the rat. Funct. Neurology. 15:2000;19-27.
25. Vasko M.R. Prostaglandin-induced neuropeptide release from spinal cord. Neuropeptides in the Spinal Cord. 1995;367-380.
26. Wei E.P., Moskowitz M.A., Boccalini P., Kontos H.A. Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilation in feline cerebral arterioles. Circ. Res. 70:1992;1313-1319.
27. White R.P., Deane C., Hindley C., Bloomfield P.M., Cunningham V.J., Vallance P., Brooks D.J., Markus H.S. The effect of the nitric oxide donor glyceryl trinitrate on global and regional cerebral blood flow in man. J. Neurol. Sci. 178:2000;23-28.
28. Williamson D.J., Hargreaves R.J. Neurogenic inflammation in the context of migraine. Microsc. Res. Tech. 53:2001;167-178.
29. Williamson D.J., Hargreaves R.J., Hill R.G., Shepheard S.L. Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat - intravital microscope studies. Cephalalgia. 17:1997;525-531.
30. Williamson D.J., Shepheard S.L., Hill R.G., Hargreaves R.J. The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilatation and extravasation. Eur. J. Pharmacol. 328:1997;61-64.
31. 1B/1D agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs. Br. J. Pharmacol. 133:2001;1029-1034.
32. Williamson D.J., Shepheard S.L., Cook D.A., Hargreaves R.J., Hill R.G., Cumberbatch M.J. Role of opioid receptors in neurogenic dural vasodilation and sensitization of trigeminal neurones in anaesthetized rats. Br. J. Pharmacol. 133:2001;807-814.
33. Wolff H.G. Headache and Other Head Pain. 1948;Oxford Univ. Press, New York.